Zacks Investment Research on MSN

Here's why you should retain DexCom stock in your portfolio

DexCom, Inc. DXCM is well-positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong first-quarter 2026 ...
Forbes

Will DexCom Stock Rebound To Its 2021 Highs Of $160?

DexCom stock (NASDAQ: DXCM) currently trades at $73 per share, around 55% below the highs of $163 seen in November 2021. In comparison, Insulet stock (NASDAQ: PODD) saw its stock decline 39% over the ...